Yogeshsing Rajput, Executive Senior Manager, Indoco Remedies | Goa Pharma Summit 2022
14th October 2022 | The Fern Kesarval Hotel & Spa, Verna Plateau, Goa | 3:00 PM IST Onwards
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Intas enters into exclusive licence agreement with Syna to commercialise LB-0702 in gobal markets
Syna will develop and manufacture LB-0702 and supply the product to Intas and its worldwide affiliates
Regulatory-compliant stability testing with JMP®
Pharma stability studies can be used to assess a drug substance, a formulation, a drug product, or a packaged product
Biocatalysis: An essential tool for API synthesis
Naveen Kulkarni, CEO, Quantumzyme, explains how the area of biocatalysis is progressing quickly and the advantages it brings for…
US FDA gives tentative approval to Lupin for Drospirenone tablets
Drospirenone tablets had estimated annual sales of $141 million in the US
Sanofi and AstraZeneca win EU approval for prevention of infant RSV
The long-acting therapy, also known as nirsevimab, was given the European Union (EU) marketing authorisation for the prevention of…
Cipla beats estimates with 11 per cent rise in quarterly profit
The company has been on an acquisition spree in recent months, from buying supplement maker Endura Mass to stake purchases in…
Dr Reddy’s lines up Rs 1,500 crore capex to focus on biosimilars and injectables
The drug major also plans to utilise the capital for adding capacities to existing plants, firm up R&D activities and further…
50 million doses of Covaxin set to expire early 2023
Due to lack of product demand, production stoppage of Covaxin - a two dose jab, was initiated by Bharat Biotech earlier this year,…
Pharma industry reports 79 M&A deals in October 2022
The industry reported 102 Venture Capital (VC) deals worth $1.8 billion in October 2022, compared to the last 12-month average…